AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 4, Pages 1064
Publisher
MDPI AG
Online
2020-04-24
DOI
10.3390/cells9041064
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tissues under-vacuum to overcome suboptimal preservation
- (2019) Laura Annaratone et al. New Biotechnology
- Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
- (2018) L. Gerratana et al. CANCER TREATMENT REVIEWS
- The role of the AR/ER ratio in ER-positive breast cancer patients
- (2018) Nelson Rangel et al. ENDOCRINE-RELATED CANCER
- Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
- (2018) Yuning Liao et al. ONCOGENE
- HER2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update Summary
- (2018) Antonio C. Wolff et al. Journal of Oncology Practice
- Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis
- (2016) Mohammad A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up
- (2016) Sara Bustreo et al. BREAST CANCER RESEARCH AND TREATMENT
- The Role of Proliferation in Determining Response to Neoadjuvant Chemotherapy in Breast Cancer: A Gene Expression-Based Meta-Analysis
- (2016) D. G. Stover et al. CLINICAL CANCER RESEARCH
- Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms
- (2016) J Feng et al. ONCOGENE
- Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status
- (2016) He-Sheng Jiang et al. Oncotarget
- CCR 20th Anniversary Commentary: Gene-Expression Signature in Breast Cancer--Where Did It Start and Where Are We Now?
- (2015) I. Gingras et al. CLINICAL CANCER RESEARCH
- TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
- (2015) Antonio Colaprico et al. NUCLEIC ACIDS RESEARCH
- Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease
- (2015) Valerie N. Barton et al. Hormones & Cancer
- A Functionally Significant Cross-talk between Androgen Receptor and ErbB2 Pathways in Estrogen Receptor Negative Breast Cancer
- (2015) Ali Naderi et al. NEOPLASIA
- Complexities of androgen receptor signalling in breast cancer
- (2014) Keely M McNamara et al. ENDOCRINE-RELATED CANCER
- Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives
- (2014) Felipe Ades et al. JOURNAL OF CLINICAL ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers
- (2013) Mitsuya Itoh et al. BREAST CANCER RESEARCH AND TREATMENT
- Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling
- (2013) Susan Thrane et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
- (2013) F. E. Vera-Badillo et al. JNCI-Journal of the National Cancer Institute
- A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
- (2013) L. J. Solin et al. JNCI-Journal of the National Cancer Institute
- Prognostic value of proliferation markers expression in breast cancer
- (2013) Natalija Dedić Plavetić et al. MEDICAL ONCOLOGY
- Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
- (2012) Takayuki Iwamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Systematic Bias in Genomic Classification Due to Contaminating Non-neoplastic Tissue in Breast Tumor Samples
- (2011) Fathi Elloumi et al. BMC Medical Genomics
- FOXA1 is an independent prognostic marker for ER-positive breast cancer
- (2011) Rutika J. Mehta et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
- (2011) Min Ni et al. CANCER CELL
- Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
- (2011) Jessica L L Robinson et al. EMBO JOURNAL
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
- (2011) Laura C Collins et al. MODERN PATHOLOGY
- GOBO: Gene Expression-Based Outcome for Breast Cancer Online
- (2011) Markus Ringnér et al. PLoS One
- Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
- (2010) Isabella Castellano et al. BREAST CANCER RESEARCH AND TREATMENT
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells
- (2009) Francesca De Amicis et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen Receptor Inhibits Estrogen Receptor- Activity and Is Prognostic in Breast Cancer
- (2009) A. A. Peters et al. CANCER RESEARCH
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescencein situhybridization and microarray-based CGH analysis
- (2009) Caterina Marchiò et al. JOURNAL OF PATHOLOGY
- Gene-Expression Signatures in Breast Cancer
- (2009) Christos Sotiriou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors
- (2008) Elisa J. Cops et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Touchdown PCR for increased specificity and sensitivity in PCR amplification
- (2008) Darren J Korbie et al. Nature Protocols
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started